Month 2025-03: Delivered two key enhancements in the dapr/dapr-agents repository that strengthen release quality and broaden integration options. Business value: improved documentation validation reduces post-release issues and increases release confidence; enhanced guidance for Azure OpenAI endpoint usage enables customers to connect their own Azure OpenAI services, expanding adoption and integration capabilities.

November 2024 (EnterpriseDB/cloudnative-pg): Delivered targeted customer adopter documentation enhancements to improve credibility and onboarding. Key feature delivered: Adopters list update for Novo Nordisk, with Novo Nordisk added to ADOPTERS.md, including contact information, submission date, and a brief description of their use case, reflecting positive operator experience with the CloudNativePG operator. This work strengthens customer references, supports demand generation, and aids future onboarding and governance. The associated commit (2b0dc71181362b1a81a5b6e08c789fd00bec7f8f) documents the change and ties to issue #6142. No major bug fixes were recorded this month. Technologies demonstrated: documentation standards, version-controlled changes via Git, and collaboration with product and customer-facing teams to capture real-world adoption details. Overall impact: improved transparency for prospects, reinforced trust with enterprise adopters, and a smoother onboarding process for new customers.